Your browser doesn't support javascript.
loading
Balancing the Nanoscale Organization in Multivalent Materials for Functional Inhibition of the Programmed Death-1 Immune Checkpoint.
Paloja, Kaltrina; Weiden, Jorieke; Hellmeier, Joschka; Eklund, Alexandra S; Reinhardt, Susanne C M; Parish, Ian A; Jungmann, Ralf; Bastings, Maartje M C.
Afiliação
  • Paloja K; Programmable Biomaterials Laboratory, Institute of Materials, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.
  • Weiden J; Programmable Biomaterials Laboratory, Institute of Materials, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland.
  • Hellmeier J; Max Planck Institute of Biochemistry, Planegg 82152, Germany.
  • Eklund AS; Max Planck Institute of Biochemistry, Planegg 82152, Germany.
  • Reinhardt SCM; Max Planck Institute of Biochemistry, Planegg 82152, Germany.
  • Parish IA; Faculty of Physics and Center for Nanoscience, Ludwig Maximilian University, Munich 80539, Germany.
  • Jungmann R; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Bastings MMC; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3128, Australia.
ACS Nano ; 18(2): 1381-1395, 2024 Jan 16.
Article em En | MEDLINE | ID: mdl-38126310
ABSTRACT
Dendritic cells (DCs) regulate immune priming by expressing programmed death ligand 1 (PD-L1) and PD-L2, which interact with the inhibitory receptor PD-1 on activated T cells. PD-1 signaling regulates T cell effector functions and limits autoimmunity. Tumor cells can hijack this pathway by overexpressing PD-L1 to suppress antitumor T cell responses. Blocking this inhibitory pathway has been beneficial for the treatment of various cancer types, although only a subset of patients responds. A deepened understanding of the spatial organization and molecular interplay between PD-1 and its ligands may inform the design of more efficacious nanotherapeutics. We visualized the natural molecular PD-L1 organization on DCs by DNA-PAINT microscopy and created a template to engineer DNA-based nanoclusters presenting PD-1 at defined valencies, distances, and patterns. These multivalent nanomaterials were examined for their cellular binding and blocking ability. Our data show that PD-1 nano-organization has profound effects on ligand interaction and that the valency of PD-1 molecules modulates the effectiveness in restoring T cell function. This work highlights the power of spatially controlled functional materials to unravel the importance of multivalent patterns in the PD-1 pathway and presents alternative design strategies for immune-engineering.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article